Will Goodman retired as a partner at Bradley. Over his 44 year legal career, Will defended agricultural, chemical, and pharmaceutical companies in high-stakes commercial and personal injury litigation. He practiced with the firm’s Life Sciences Litigation team and co-chaired the Food and Agriculture Litigation and Regulatory team. From 2008-2021, Will was nationally ranked for Product Liability and Mass Torts by Chambers USA for his litigation experience in challenging venues throughout the United States. Will was admitted to practice law in Mississippi and Tennessee, and was admitted pro hac vice for particular matters in many state and federal courts across the country.
Will had significant case management, discovery, and trial experience in major chemical exposure, class action, commercial, and pharmaceutical litigations, most of which involved hundreds or thousands of claims. His chemical exposure litigation experience included asbestos, dioxin, isocyanate, and toxic waste site/Superfund-related litigations. He also focused on the national level defense of pharmaceutical and chemical companies in complex commercial and personal injury litigation. Will was involved in the defense of 16 pharmaceutical litigations, and he served as regional and trial counsel on national commercial litigation involving genetically modified crops. Through these engagements, he prepared and defended numerous key company witnesses for depositions taken in Asia and Europe.
Will was selected for special discovery and trial teams in several national litigations. He tried cases to verdict in Arkansas, California, and Mississippi. These trials included defense verdicts for Bayer in the second and third trials in the country involving the prescription medicine Baycol. He was selected for trial teams in cases that resolved before or during trial in Alabama, Arizona, Kentucky, Louisiana, Oklahoma, Pennsylvania, Tennessee, and Texas.
Will was a lead presenter in numerous jury exercises conducted in seven different states.